Evidence map›Paper›PMID 33981252›Full record

ArticleFrontiers in physiology2021

Microglial Activation Is Associated With Vasoprotection in a Rat Model of Inflammatory Retinal Vasoregression.

Sarah Riemann, Matthias Kolibabka, Stephanie Busch, Jihong Lin, Sigrid Hoffmann, Norbert Gretz, Yuxi Feng, Paulus Wohlfart, Hans-Peter Hammes

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Sarah Riemann5th Medical Department, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Matthias Kolibabka5th Medical Department, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Stephanie Busch5th Medical Department, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Jihong Lin5th Medical Department, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Sigrid HoffmannMedical Research Center, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Norbert GretzMedical Research Center, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Yuxi FengExperimental Pharmacology, European Center for Angioscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Paulus WohlfartSanofi Aventis Deutschland GmbH, TA Diabetes R&D, Frankfurt, Germany.
Hans-Peter Hammes5th Medical Department, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Heidelberg University · DEUniversity Hospital Heidelberg · DEUniversity Medical Centre Mannheim · DESanofi (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vascular dysfunction and vasoregression are hallmarks of a variety of inflammatory central nervous system disorders and inflammation-related retinal diseases like diabetic retinopathy. Activation of microglia and the humoral innate immune system are contributing factors. Anti-inflammatory approaches have been proposed as therapies for neurovascular diseases, which include the modulation of microglial activation. The present study aimed at investigating the effects of microglial activation by clodronate-coated liposomes on vasoregression in a model of retinal degeneration. Clodronate treatment over 5 weeks led to an increase in activated CD74

Indexed as

clodronatemicrogliapericyteretinopathyvasoregression

Identifiers

PMID33981252
PMCPMC8107726
OpenAlexW3162529469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.